T2 BIOSYSTEMS INC (TTOO)

T2 Biosystems Announces Sale of Four T2Dx Instruments to Existing European Distributor

Multiple instrument sale demonstrates growing market penetration of T2 Biosystems’ sepsis tests...

T2 Biosystems Achieves Key Milestone with 250,000th Novel Sepsis Test Shipped Globally

Milestone demonstrates the growing customer adoption of the Company’s proprietary technology...

Get insights into the top gainers and losers of Monday's after-hours session.

The US market regular session of Monday is over, let's have a look at the top gainers and losers in the after hours session today.

T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc.

LEXINGTON, Mass., Dec. 16, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO), a leader in the rapid detection of sepsis-causing pathogens and...

T2 Biosystems Announces Plans to License its Proprietary Technology to Expand its Leadership in Direct-From-Whole-Blood Detection of Sepsis-Causing Pathogens

Intends to accelerate broad adoption of direct-from-whole-blood diagnostics, generate non-dilutive capital, and create a new royalty revenue stream...

T2 Biosystems Announces Third Quarter 2024 Financial Results

Achieved 34% quarterly revenue growth compared to the prior year period...

T2 Biosystems to Report Third Quarter 2024 Financial Results and Business Updates on November 14, 2024

LEXINGTON, Mass., Nov. 05, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and...

T2 Biosystems to Host Business Update Call on October 10, 2024

LEXINGTON, Mass., Oct. 08, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and...

T2 Biosystems Announces Exclusive U.S. Agreement with Cardinal Health to Sell its FDA-Cleared Direct-From-Blood Diagnostics for Rapid Detection of Sepsis-Causing Pathogens

LEXINGTON, Mass., Oct. 07, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing...

T2 Biosystems Announces Preliminary Third Quarter 2024 Financial Results

Achieved 35% increase in total revenue compared to prior year period...

T2 Biosystems Highlights New Article Published in The Lancet: Changing the Culture of Blood Culture

LEXINGTON, Mass., Sept. 23, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO) (the “Company”), a leader in the rapid detection of...

T2 Biosystems Achieves Successful Defense of Patent for Direct-From-Whole Blood Pathogen Detection Method in the European Union

LEXINGTON, Mass., Sept. 20, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing...

T2 Biosystems Receives FDA Clearance to Market the T2Candida Panel for Pediatric Patients

Expands available market to include over 200 children’s hospitals in the United States...

T2 Biosystems Provides Updates on its New Product Development Pipeline Progress

Company plans to launch multiple direct-from-blood diagnostics over the next 15 months for antimicrobial resistance, pediatric Candida infections, Lyme...

T2 Biosystems to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

LEXINGTON, Mass., Aug. 27, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and...

Sidoti Events, LLC's Virtual August Micro-Cap Conference

T2 Biosystems to Attend Upcoming Investor Conferences

LEXINGTON, Mass., Aug. 01, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

Pre-market stock movers are a hot topic as we jump into all of the biggest news that has shares heading higher and lower on Tuesday morning!

TTOO Stock Earnings: T2 Biosystems Beats EPS, Misses Revenue for Q2 2024

TTOO stock results show that T2 Biosystems beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.

TTOO Stock Earnings: T2 Biosystems Beats EPS, Misses Revenue for Q2 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips T2 Biosystems (NASDAQ:TTOO) just reported results for the second quarter of 202...

T2 Biosystems Announces Second Quarter 2024 Financial Results

Achieved record quarterly and first half sepsis test revenue, representing growth of 27% and 25% respectively compared to the prior year periods...

T2 Biosystems Announces Commercial Expansion Through Malaysia and Indonesia Distributor

LEXINGTON, Mass., July 29, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and...

T2 Biosystems to Report Second Quarter 2024 Financial Results and Business Updates on July 29, 2024

LEXINGTON, Mass., July 22, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and...

T2 Biosystems Announces Commercial Expansion Through Hong Kong and Macau Distributor

LEXINGTON, Mass., June 25, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and...

T2 Biosystems Regains Compliance with Nasdaq Continued Listing Requirements

LEXINGTON, Mass., May 22, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing...

T2 Biosystems Announces Closing of $8 Million Private Placement Priced At-The-Market Under Nasdaq Rules

LEXINGTON, Mass., May 17, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and...

T2 Biosystems Announces CRG’s Conversion from Preferred Stock to Common Stock

LEXINGTON, Mass., May 14, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing...

T2 Biosystems Announces Letter of Intent to Enter Strategic Partnership for Lyme Disease

Advances plan to launch T2Lyme Panel for detection of early Lyme disease...

TTOO Stock Earnings: T2 Biosystems Misses EPS, Beats Revenue for Q1 2024

TTOO stock results show that T2 Biosystems missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.

TTOO Stock Earnings: T2 Biosystems Misses EPS, Beats Revenue for Q1 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips T2 Biosystems (NASDAQ:TTOO) just reported results for the first quarter of 2024...

T2 Biosystems Announces First Quarter 2024 Financial Results

Achieved double-digit growth in sepsis product revenue and reduced debt by approximately 80% compared to the prior year period...

T2 Biosystems Announces Commercial Expansion Through Middle East Distributor

Filed Pursuant to Rule 433 Issuer Free Writing Prospectus dated May 6, 2024 Relating to Preliminary Prospectus dated May 6, 2024 Registration No....

T2 Biosystems Announces the Conversion of an Additional $15 Million of CRG Term Loan into Equity

Strengthens balance sheet by reducing total debt by approximately 80% over the past year...

T2 Biosystems to Report First Quarter 2024 Financial Results and Business Updates on May 6, 2024

LEXINGTON, Mass., April 24, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and...